Stay updated on Pembrolizumab and Lenvatinib in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 to reflect a newer version of the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedRecruitment status on the study page now shows 'No longer looking for participants,' indicating enrollment is complete. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label, with the revision tag updated to v3.6.0.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing Revision: v3.5.4. This indicates the page's revision was updated to a newer version.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page's revision tag updated from v3.5.3 to v3.5.4, indicating a minor update to the study details page metadata. This reflects an internal revision rather than changes to the study data or content.SummaryDifference0.0%

- Check70 days agoChange DetectedUpdates the Chile location listing to use shorter region labels (e.g., Araucania and Valparaiso) alongside the corresponding city/state entries, and updates the displayed site revision version.SummaryDifference0.4%

- Check77 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Lenvatinib in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.